This data on Rb may overlap with recent work indicating that many classic “tumor suppressors” may be “double agents” by acting in an oncogenic manner, as perhaps exemplified by Rb nuclear interactions with BAG-1 [190]. The gene discussed is BAG1; the disease is neoplasm.